The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Disease-free (DFS) and overall survival (OS) at 3.4 years (yrs) for neoadjuvant bevacizumab (Bev) added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide (D-FEC), for women with HER2 negative early breast cancer: The ARTemis trial.
 
Helena Margaret Earl
Consulting or Advisory Role - AstraZeneca; Celgene; Pfizer; Roche
Research Funding - PharmaMar (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Louise Hiller
No Relationships to Disclose
 
Janet Dunn
No Relationships to Disclose
 
Clare Blenkinsop
No Relationships to Disclose
 
Louise Grybowicz
No Relationships to Disclose
 
Anne-Laure Vallier
No Relationships to Disclose
 
Jean Abraham
Research Funding - AstraZeneca (Inst)
 
Luke Hughes-Davies
No Relationships to Disclose
 
Karen McAdam
Consulting or Advisory Role - AstraZeneca; Novartis
 
Stephen Chan
No Relationships to Disclose
 
Rizvana Ahmad
No Relationships to Disclose
 
Tamas Hickish
Leadership - Knowledge To Practice
Stock and Other Ownership Interests - Knowledge To Practice
Research Funding - XBiotech
Patents, Royalties, Other Intellectual Property - Bournemouth University
 
Stephen Houston
No Relationships to Disclose
 
Daniel Rea
Honoraria - Roche/Genentech
Research Funding - Celgene (Inst); Roche (Inst)
 
John Bartlett
Consulting or Advisory Role - BioNTech; Insight Genetics
Patents, Royalties, Other Intellectual Property - Method and Apparatus for Predicting Risk in Breast Cancer (Inst); Methods and devices for predicting anthracycline treatment (Inst); Systems, Devices and methods for constructing and using a biomarker (Inst)
 
Carlos Caldas
Research Funding - Genentech (Inst)
 
David A. Cameron
Research Funding - Celgene (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Elena Provenzano
No Relationships to Disclose
 
Jeremy Thomas
No Relationships to Disclose
 
Larry Hayward
Research Funding - Celgene (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Novartis; Roche